Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash.

Salix Pharmaceuticals (NASDAQ: SLXP) had $775.90 million in total cash and $869.10 million in total debt for the latest quarter.

Mylan (NASDAQ: MYL) had $412.67 million in total cash for the latest quarter. However, Mylan had $5.37 billion in total debt for the same period.

Hi Tech Pharmacal Co (NASDAQ: HITK) had $104.09 million in total cash and $1.42 million in total debt for the latest quarter.

Akorn (NASDAQ: AKRX) had $38.40 million in total cash and $103.65 million in total debt for the latest quarter.